Examining the Role of Nutrition in Crohn’s Disease and Ulcerative Colitis
Emerging evidence underscores the significant impact of diet on IBD development and treatment.
Read More
Dissemination (Spotlight)
Exploring the Benefits of Deep Brain Stimulation in Tardive Dyskinesia
Deep brain stimulation offers advantages such as adjustability, reversibility, and the potential for rapid and long-term improvement in tardive dyskinesia.
Read More
The Potential of Microbiota Manipulation in IBD Treatment
Targeted microbiota manipulation using probiotics, prebiotics, synbiotics, and fecal microbiota transplantation holds potential for IBD treatment.
Read More
Tools for Measuring Tardive Dyskinesia: Clinical Implementation & Recent Advancements
Annual training and reliable new tools can help physicians improve tardive dyskinesia screening and symptom measurement.
Read More
Addressing Insomnia & Mental Health in Crohn’s Disease
Patients with inflammatory bowel diseases often experience insomnia and various mental health conditions that healthcare providers should monitor.
Read More
Western World Reports Improved Hospitalization Stability for Crohn’s & Colitis
Advances in the management of IBD may support a shift from hospital-based care to community-based care.
Read More
Tardive Dyskinesia: A Comprehensive Look at the Condition and Its Management
There are approximately 600,000 people in the US who are living with TD—65% of them have not been diagnosed.
Read More
Switching from IV to Subcutaneous Vedolizumab Deemed Safe & Effective
Study results indicate that switching from intravenous to subcutaneous vedolizumab in patients with IBD appears to be safe and effective.
Read More
The Tardive Dyskinesia Impact Scale Provides a Holistic Evaluation for Physicians
The Tardive Dyskinesia Impact Scale complements the Abnormal Involuntary Movement Scale by combining clinician-rated and patient-reported perspectives.
Read More
Extrapyramidal Rating Scale Effectively Measures Tardive Dyskinesia Symptoms
The Extrapyramidal Symptom Rating Scale and an abbreviated version of the scale were both validated for measuring the impact of tardive dyskinesia.
Read More
82% of Caregivers Say Tardive Dyskinesia Severely Impacts Patients
Tardive dyskinesia impacts both the patients living with the movement disorder and those who care for them.
Read More
Patients’ Views on Impact of Tardive Dyskinesia Challenge Clinician Assessments
Patients consistently felt possible TD impacted their lives, regardless of rating method, suggesting clinician assessments might miss its actual burden.
Read More
Potential Link Found Between Immune Reactions & Tardive Dyskinesia
Researchers proposed a hypothesis linking dysfunctions in the striatum and the dorsal diencephalic connection system (DDCS) to classic tardive dyskinesia (TD).
Read More
RECIP 1.0’s Prognostic Value in Biochemically Recurrent Prostate Cancer Imaging
The following is a summary of “Prognostic utility of RECIP 1.0 with manual and AI-based...
Read More
Mortality Risk Comparable With Continuous Versus Intermittent ADT for Prostate Cancer
An analysis of 12 clinical trials shows no difference in mortality risk with continuous versus intermittent androgen deprivation therapy for prostate cancer.
Read More
Caring for Patients With Tardive Dyskinesia Can Present Challenges
Healthcare professionals should consider a complete therapeutic approach that includes the input of caregivers assisting patents with TD.
Read More
In Clinical Trial Setting, Survival Is Similar for Black & White Patients With Prostate Cancer
Both Black and White patients with metastatic castration-sensitive prostate cancer (mCSPC) showed similar progression-free survival and overall survival in a clinical trial setting.
Read More
Metastatic Prostate Cancer With BRCA Deficiency has a Poor Prognosis & a Unique Genetic Profile
The following is a summary of “BRCA-deficient metastatic prostate cancer has an adverse...
Read More
Functional MRI Identifies Changes in Cerebral Regional Homogeneity Among Patients With TD
Resting-state functional MRI results show that patients with schizophrenia and tardive dyskinesia have altered cerebral regional homogeneity.
Read More
Telehealth Complements In-Person Visits for Tardive Dyskinesia
Physicians typically address movement disorders, such as tardive dyskinesia, during in-person examinations; however, a recent study shows that telehealth visits can be a part of treatment plans.
Read More